Fate Therapeutics
IPO
- Headquarters
- La Jolla, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- fatetherapeutics.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series BNov 2009
About
Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for autoimmune diseases and cancer.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account